Beta-lactam enhancement against methicillin-resistant Staphylococcus aureus by cell wall blockade is autolysis-dependent: a butyrolactone derivative as case in point
Magdum, P. M.; Grissom, J. N.; Franey, B. T.; Ullah, S.; Abdelaziz, M. H.; North, J.; Sarkar, A.
Show abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is non-susceptible to beta-lactams. Blockade of cell wall biosynthesis is a potential target for beta-lactam enhancement but requires further investigation. A butyrolactone derivative enhanced beta-lactams against MRSA strains by reducing the availability of D-Ala-D-Ala. Unlike D-cycloserine, it did not inhibit D-Ala-D-Ala ligase (Ddl). Nor did it show an additive or synergistic effect when combined with cycloserine, indicating a unique mechanism for blocking cell wall precursor production that does not involve the traditional Lipid II pathway. Notably, beta-lactam potentiation by our chemical or D-cycloserine was highly dependent on the intrinsic autolytic ability of the tested MRSA strains. Strains that resisted lysis upon Triton X-100 exposure showed a minimal increase in beta-lactam susceptibility, whereas highly autolytic strains showed significant changes in their beta-lactam MICs. We have thus identified autolytic ability as the Achilles Heel in the strategy of targeting cell wall biosynthesis for beta-lactam potentiation.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Antibiotic-adjuvants abolish resistance conferred by the Staphylococcus aureus erythromycin resistance methyltransferase in an Escherichia coli model 92%
- Broad-Spectrum Activity and Mechanisms of Action of SQ109 on a Variety of Fungi 92%
- An engineered prodrug selectively suppresses β-lactam resistant bacteria in a mixed microbial setting 91%
Similar papers in this journal
Similar papers in this journal
- Mode of action of the antimicrobial peptide Mel4 is independent of Staphylococcus aureus cell membrane permeability 92%
- Drug screening to identify compounds to act as co-therapies for the treatment of pathogenic Burkholderia 92%
- Assessment of Phenotype Microarray plates for rapid and high-throughput analysis of collateral sensitivity networks 91%
Similar papers in this journal
- Targeted Sortase A Inhibition by Novel Peptidomimetic Antivirulents against Staphylococcal Infections 95%
- Polyether ionophore antibiotics target drug-resistant clinical isolates, persister cells, and biofilms 94%
- Novel Pentafluorosulfanyl-containing Triclocarban Analogs selectively kill Gram-positive bacteria. 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.